InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Nabulsi Azmi, Chief Operating Officer. Director active across 1 companies, notably Phathom Pharmaceuticals, Inc.. Aggregated, 6 disclosures have been recorded. Total volume traded: €426k. The latest transaction was disclosed on 19 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
012,000 shares0
Common Stock
SEC:0001209191-22-031090:0·
€156,42220,000 shares@ €7.82110.017% mcap36.7% of flow
Common Stock
SEC:0001209191-22-029453:0·
Ideal exit: 10 Feb 2023 (T+270)
019,500 shares0
Common Stock
SEC:0001209191-22-004496·
019,500 shares0
Common Stock
SEC:0001209191-22-004496:0·
€134,6124,290 shares@ €31.37820.014% mcap100.0% of flow
Common Stock
SEC:0001209191-21-030141·
€134,6124,290 shares@ €31.37820.014% mcap31.6% of flow
Common Stock
SEC:0001209191-21-030141:0·
6 of 6 declarations
About Nabulsi Azmi
Azmi Nabulsi is the Chief Operating Officer at Phathom Pharmaceuticals, Inc. He is responsible for overseeing daily operations and ensuring process efficiency. Azmi brings expertise in operational management and strategy, contributing to the achievement of the company's objectives and continuous performance improvement.
